Please login to the form below

Not currently logged in
Email:
Password:

The Carlyle Group appoints Essner

The Carlyle Group, a global private equity firm, has appointed former Wyeth CEO, Robert Essner, as senior advisor to its global healthcare group

The Carlyle Group, a global private equity firm, has appointed Robert Essner, former CEO and chairman of the board at Wyeth, as senior advisor to its global healthcare group.

Essner will provide strategic guidance to Carlyle professionals throughout the healthcare investment process, from sourcing to purchasing, and advise portfolio company executives on management, operational and growth strategies. He joins a group of talented senior executives who serve as Carlyle Senior Advisors across a spectrum of industries.

Karen Bechtel, Carlyle MD and head of the global healthcare group, said: "Bob's leadership experience and value creation abilities will add to the depth and scope of our ability to find and make compelling investments in the global healthcare space. We are so pleased he has agreed to be a part of our group."

Essner said: "I am excited to join Carlyle and partner with the Carlyle healthcare team. We see a range of opportunities in the US and globally for private capital to help strengthen and improve the efficiency and effectiveness of the healthcare sector."

Essner served at Wyeth from 1989-2008, where he led Wyeth's transformation into a global leader in biotechnology and vaccines. He worked his way up from senior vice president, sales and marketing to CEO and chairman.

8th April 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics